We are live on ! Find out more
TCRT icon

Alaunos Therapeutics
TCRT

29 hedge funds and large institutions have $361K invested in Alaunos Therapeutics in 2026 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 1

50% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 4

7% more funds holding

Funds holding: 27 → 29 (+2)

3% more capital invested

Capital invested by funds: $350K → $361K (+$10.6K)

0.75% more ownership

Funds ownership: 4.68% → 5.42% (+0.75%)

Holders
29
Holders Change
+2
Holders Change %
+7.41%
% of All Funds
0.36%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
6
Reduced
4
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$31.5K
2
XT
XTX Topco
Cayman Islands
+$30.4K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$8.45K
4
UBS Group
UBS Group
Switzerland
+$2.89K
5
HF
HRT Financial
New York
+$2.17K

Top Sellers

Rank Fund Capital Flow
1
Two Sigma Investments
Two Sigma Investments
New York
-$23.2K
2
Morgan Stanley
Morgan Stanley
New York
-$2.97K
3
Bank of America
Bank of America
North Carolina
-$287
4
Citigroup
Citigroup
New York
-$263
5
II
Inspire Investing
Idaho
-$3
Name Holding Trade Value Shares
Change 		Change in
Stake
Geode Capital Management
1
Geode Capital Management
Massachusetts
$64.5K +$8.45K +2,824 +14%
BlackRock
2
BlackRock
New York
$61.1K – – –
VFT
3
Vanguard Fiduciary Trust
Pennsylvania
$44.3K +$46.3K +15,497 New
VCM
4
Vanguard Capital Management
Pennsylvania
$40.2K +$42.1K +14,063 New
HF
5
HRT Financial
New York
$38K +$2.17K +725 +6%
Two Sigma Investments
6
Two Sigma Investments
New York
$31K -$23.2K -7,749 -42%
Citadel Advisors
7
Citadel Advisors
Florida
$30.1K +$31.5K +10,519 New
XT
8
XTX Topco
Cayman Islands
$29.1K +$30.4K +10,174 New
UBS Group
9
UBS Group
Switzerland
$6.5K +$2.89K +965 +74%
Osaic Holdings
10
Osaic Holdings
Arizona
$5.08K +$2.1K +703 +65%
TRCT
11
Tower Research Capital (TRC)
New York
$4.53K +$1.5K +502 +46%
Morgan Stanley
12
Morgan Stanley
New York
$1.87K -$2.97K -994 -60%
VGA
13
Vanguard Global Advisers
Pennsylvania
$1.43K +$1.5K +501 New
Royal Bank of Canada
14
Royal Bank of Canada
Ontario, Canada
$1K +$553 +185 New
Wells Fargo
15
Wells Fargo
California
$543 +$36 +12 +7%
BTI
16
Blue Trust Inc
Georgia
$386 – – –
SPIA
17
Steward Partners Investment Advisory
New York
$263 – – –
FDCDDQ
18
Federation des caisses Desjardins du Quebec
Quebec, Canada
$200 – – –
KFI
19
Key Financial Inc
Pennsylvania
$69 – – –
S
20
SignatureFD
Georgia
$66 – – –
NFSG
21
Newbridge Financial Services Group
Florida
$60 – – –
NS
22
NBC Securities
Alabama
$57 – – –
AF
23
Advisornet Financial
Minnesota
$54 – – –
SS
24
Sunbelt Securities
Texas
$29 – – –
II
25
Inspire Investing
Idaho
$25 -$3 -1 -10%
1
2

TCRT Hedge Fund Activity: Q1 2026 in Review

29 of the 8,137 institutional investors tracked by Wall St. Rank reported a position in Alaunos Therapeutics (TCRT) for Q1 2026, worth a combined $361K — up 3% from $350K a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new TCRT positions and 1 closed out — a net gain of 5 holders — while 6 added to existing stakes and 4 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $31.5K. The largest seller was Two Sigma Investments, cutting an estimated $23.2K.

  • 29 institutional investors held Alaunos Therapeutics (TCRT) as of Q1 2026, up from 27 in Q4 2025.
  • Funds reported $361K of Alaunos Therapeutics stock for Q1 2026, up 3% quarter-over-quarter.
  • 6 funds opened new Alaunos Therapeutics positions in Q1 2026 and 1 closed out, a net change of +5 holders.
  • The largest Alaunos Therapeutics buyer in Q1 2026 was Citadel Advisors, an estimated $31.5K added.
  • The largest Alaunos Therapeutics seller in Q1 2026 was Two Sigma Investments, an estimated $23.2K sold.

Based on aggregated 13F filings for Q1 2026.